Publications acknowledging the platform
2026
Karavaeva I, et al. Mitochondrial carrier SLC25A34 links clock, diet, and temperature control of adipocyte lipid cycling. Science. 2026 Oct;394(6819):eadz4797. doi: 10.1126/science.adz4797. Epub 2026 Oct 1.
Finger F, et al. Mitochondrial membrane lipid cardiolipin controls fiber-type adaptations in aging muscle via estrogen-related receptor γ. Nat Aging. 2026 Sep 29. doi: 10.1038/s43587-026-01227-7. Epub ahead of print.
Brown JM, et al. Single-cell profiling identifies obesity-disrupted brain glucose sensing. Nat Commun. 2026 Aug 31. doi:10.1038/s41467-026-77116-9.
Hunt JE, et al. Novel Long-Acting Ghrelin Analogue PEP-064 Restores Energy Balance in C26 and Lewis Lung Carcinoma-Induced cachexia in Mice. J Cachexia Sarcopenia Muscle. 2026 Jun;17(3):e70318. doi: 10.1002/jcsm.70318.
Aalling NN, et al. Sustained diabetes remission induced by FGF1 involves a shift in transcriptionally distinct AgRP neuron subpopulations. Mol Metab. 2026 Jan;103:102300. doi: 10.1016/j.molmet.2025.102300. Epub 2025 Dec 9.
Kuentzel KB, et al. Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models. J Hepatol. 2026 Sep;85(3):479-492. doi: 10.1016/j.jhep.2026.04.033. Epub 2026 May 9.
Ludwig MQ, et al. A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance. Nat Metab. 2026 Jun;8(6):1350-1367. doi: 10.1038/s42255-026-01539-3. Epub 2026 Jun 8.
Kuentzel KB, et al. Omega-3 fatty acid supplementation improves skeletal muscle mitochondrial function in a model of Barth syndrome. JCI Insight. 2026 Jun 9;11(15):e196134. doi: 10.1172/jci.insight.196134. eCollection 2026 Aug 10.
Luda KM, et al. Chronic viral infection aggravates white adipose tissue dysfunction and liver pathology in obesity. Mol Metab. 2026 Aug;110:102394. doi: 10.1016/j.molmet.2026.102394. Epub 2026 Jun 9.
2025
Brachs S, et al. Robust noninvasive detection of hyperglycemia in mouse models of metabolic dysregulation using the novel Urination Index biomarker. Lab Anim (NY). 2025 Dec;54(12):379-389. doi: 10.1038/s41684-025-01648-8. Epub 2025 Nov 21.
Dall M, et al. Hepatocyte dedifferentiation in 2D culture reveals extensive transcriptomic and proteomic rewiring. Hepatol Commun. 2025 Oct 7;9(11):e0795. doi: 10.1097/HC9.0000000000000795.
Ehrlich AM, et al. HIF1α mediates circadian regulation of skeletal muscle metabolism and substrate preference in response to time-of-day exercise. Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2504080122. doi: 10.1073/pnas.2504080122. Epub 2025 Jul 8.
Holm SK, et al. Sustained Weight Loss With Combined LEAP2 and Semaglutide Treatment in Mice. Diabetes. 2025 Jul 1:db241056. doi: 10.2337/db24-1056. Epub ahead of print.
Chubanava S, et al. NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging. Cell Metab. 2025 Apr 30:S1550-4131(25)00212-8. doi: 10.1016/j.cmet.2025.04.002. Epub ahead of print.
Ranea-Robles P, et al. Time-Resolved Effects of Short-term Overfeeding on Energy Balance in Mice. Diabetes. 2025 Apr 1;74(4):502-513. doi: 10.2337/db24-0289.
Gil CRE, et al. Food insecurity promotes adiposity in mice. Obesity (Silver Spring). 2025 Mar 23. doi: 10.1002/oby.24259. Epub ahead of print.
Lansbury EL, et al. Neurons Co-Expressing GLP-1, CCK, and PYY Receptors Particularly in Right Nodose Ganglion and Innervating Entire GI Tract in Mice. Int J Mol Sci. 2025 Feb 26;26(5):2053. doi: 10.3390/ijms26052053.
Ashcroft SP, et al. Enhanced metabolic adaptations following late dark phase wheel running in high-fat diet-fed mice. Mol Metab. 2025 May;95:102116. doi: 10.1016/j.molmet.2025.102116. Epub 2025 Feb 22.
Dall M, et al. Our future, we decide: five ways to reform the scientific publication process. Nat Rev Endocrinol. 2025 Jan;21(1):5-6. doi: 10.1038/s41574-024-01056-x.
Ranea-Robles P, et al. Time-Resolved Effects of Short-term Overfeeding on Energy Balance in Mice. Diabetes. 2025 Apr 1;74(4):502-513. doi: 10.2337/db24-0289.
Galsgaard KD, et al. Female glucagon receptor knockout mice are prone to steatosis but resistant to weight gain when fed a MASH-promoting GAN diet and a high-fat diet. Physiol Rep. 2025 Feb;13(4):e70235. doi: 10.14814/phy2.70235.
Banks AS, et al. A consensus guide to preclinical indirect calorimetry experiments. Nat Metab. 2025 Sep;7(9):1765-1780. doi: 10.1038/s42255-025-01360-4. Epub 2025 Sep 24.
2024
Sass F, et al. NK2R control of energy expenditure and feeding to treat metabolic diseases. Nature. 2024 Nov;635(8040):987-1000. doi: 10.1038/s41586-024-08207-0. Epub 2024 Nov 13.
Petersen J, et al. Lead-in calorie restriction enhances the weight-lowering efficacy of incretin hormone-based pharmacotherapies in mice. Mol Metab. 2024 Nov;89:102027. doi: 10.1016/j.molmet.2024.102027. Epub 2024 Sep 13.
Petersen J, et al. GLP-1-directed NMDA receptor antagonism for obesity treatment. Nature. 2024 May;629(8014):1133-1141. doi: 10.1038/s41586-024-07419-8. Epub 2024 May 15.
Pendergrast LA, et al. Metabolic plasticity and obesity-associated changes in diurnal postexercise metabolism in mice. Metabolism. 2024 Mar 11:155834. doi: 10.1016/j.metabol.2024.155834. Epub ahead of print.
Fadahunsi N, et al. Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatment. Sci Adv. 2024 Mar;10(9):eadg2636. doi: 10.1126/sciadv.adg2636. Epub 2024 Mar 1.
Lund C, et al. Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R. Nat Commun. 2024 Feb 8;15(1):1192. doi: 10.1038/s41467-024-45223-0.
2023
Lund J, et al. The anorectic and thermogenic effects of pharmacological lactate in male mice are confounded by treatment osmolarity and co-administered counterions. Nat Metab. 2023 Apr;5(4):677-698. doi: 10.1038/s42255-023-00780-4. Epub 2023 Apr 13.
Basse AL, et al. NAMPT-dependent NAD+ biosynthesis controls circadian metabolism in a tissue-specific manner. Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2220102120. doi: 10.1073/pnas.2220102120. Epub 2023 Mar 30.
Peluso AA, et al. Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans. NPJ Aging. 2023 Apr 3;9(1):7. doi: 10.1038/s41514-023-00106-4.
Dall M, et al. Denmark's big tent includes postdocs. Science. 2023 Apr 14;380(6641):143. doi: 10.1126/science.adh4261. Epub 2023 Apr 13.
Falk S, et al. GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity. Cell Rep. 2023 May 30;42(5):112466. doi: 10.1016/j.celrep.2023.112466. Epub 2023 May 5.
Small L, et al. Seasonal light hours modulate peripheral clocks and energy metabolism in mice. Cell Metab. 2023 Oct 3;35(10):1722-1735.e5. doi: 10.1016/j.cmet.2023.08.005. Epub 2023 Sep 8.
2022
Damgaard MV, et al. Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD+ without impacting respiratory capacity or insulin sensitivity. iScience. 2022 Feb 2;25(2):103863. doi: 10.1016/j.isci.2022.103863.
2021
Grunddal KV, et al. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist. Mol Metab. 2021 Jul;49:101207. doi: 10.1016/j.molmet.2021.101207. Epub 2021 Mar 9.
Grevengoed TJ, et al. An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides. J Clin Invest. 2021 Mar 15;131(6):e143861. doi: 10.1172/JCI143861.
Lubberding AF, et al. Age-dependent transition from islet insulin hypersecretion to hyposecretion in mice with the long QT-syndrome loss-of-function mutation Kcnq1-A340V. Sci Rep. 2021 Jun 10;11(1):12253. doi: 10.1038/s41598-021-90452-8.
Sveidahl Johansen O, et al. Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis. Cell. 2021 Jun 24;184(13):3502-3518.e33. doi: 10.1016/j.cell.2021.04.037. Epub 2021 May 27.
Tozzi M, et al. Dynamic interplay between AfadinS1795 phosphorylation and diet regulates glucose homeostasis in obese mice. J Physiol. 2022 Feb;600(4):885-902. doi: 10.1113/JP281657. Epub 2021 Sep 1.
Gonzalez-Franquesa A, et al. Discovery of thymosin β4 as a human exerkine and growth factor. Am J Physiol Cell Physiol. 2021 Nov 1;321(5):C770-C778. doi: 10.1152/ajpcell.00263.2021. Epub 2021 Sep 8.
Dall M, et al. Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. J Biol Chem. 2021 Dec;297(6):101388. doi: 10.1016/j.jbc.2021.101388. Epub 2021 Nov 8.
2020
de Guia RM, et al. Fasting- and ghrelin-induced food intake is regulated by NAMPT in the hypothalamus. Acta Physiol (Oxf). 2020 Apr;228(4):e13437. doi: 10.1111/apha.13437. Epub 2020 Jan 14.
2019
Ratner C, et al. Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway. Diabetes. 2019 Jun;68(6):1329-1340. doi: 10.2337/db18-1009. Epub 2019 Apr 1.
Skov LJ, et al. RhoA in tyrosine hydroxylase neurones regulates food intake and body weight via altered sensitivity to peripheral hormones. J Neuroendocrinol. 2019 Jul;31(7):e12761. doi: 10.1111/jne.12761.
Faarkrog Høyer K, et al. Assessment of mouse liver [1-13C]pyruvate metabolism by dynamic hyperpolarized MRS. J Endocrinol. 2019 Sep 1;242(3):251-260. doi: 10.1530/JOE-19-0159.
2018
Poupeau A, et al. Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice. FASEB J. 2019 Feb;33(2):2719-2731. doi: 10.1096/fj.201800787R. Epub 2018 Oct 10.
Høyer KF, et al. Sevoflurane Impairs Insulin Secretion and Tissue-Specific Glucose Uptake In Vivo. Basic Clin Pharmacol Toxicol. 2018 Dec;123(6):732-738. doi: 10.1111/bcpt.13087. Epub 2018 Aug 24.
Park S, et al. Electrical pulse stimulation induces differential responses in insulin action in myotubes from severely obese individuals. J Physiol. 2019 Jan;597(2):449-466. doi: 10.1113/JP276990. Epub 2018 Dec 2.